Perjan Pleunis

LMB wants to lead the fight against viral threads for animals and humans through scalable, game-changing vaccine solutions, securing global health and transforming food supply chains. Our mission is to develop and commercialize the world’s first oral vaccine for avian influenza, combining breakthrough science with practical delivery methods to address a $10 billion+ market. By simplifying disease prevention for poultry producers, reducing economic losses, and mitigating zoonotic risks, we aim to deliver unparalleled value to stakeholders and ensure a sustainable, healthier future. Together with our partners and investors, we are redefining how the world protects against the threats of infectious diseases.